PTPN11 and psoriasis: For instance, SHP2 was shown to drive neutrophil extracellular trap (NET) formation via the ERK5 pathway, which enhances pro‐inflammatory cytokine release, amplifies neutrophil–keratinocyte crosstalk, and exacerbates psoriasis‐like skin lesions [38].